Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Population pharmacokinetic and pharmacodynamic analysis of tesamorelin in HIV-infected patients and healthy subjects.

González-Sales M, Barrière O, Tremblay PO, Nekka F, Mamputu JC, Boudreault S, Tanguay M.

J Pharmacokinet Pharmacodyn. 2015 Apr 21. [Epub ahead of print]

PMID:
25895899
2.

Population pharmacokinetic analysis of tesamorelin in HIV-infected patients and healthy subjects.

González-Sales M, Barrière O, Tremblay PO, Nekka F, Mamputu JC, Boudreault S, Tanguay M.

Clin Pharmacokinet. 2015 Mar;54(3):285-94. doi: 10.1007/s40262-014-0202-x.

PMID:
25358450
3.

Reduction in visceral adiposity is associated with an improved metabolic profile in HIV-infected patients receiving tesamorelin.

Stanley TL, Falutz J, Marsolais C, Morin J, Soulban G, Mamputu JC, Assaad H, Turner R, Grinspoon SK.

Clin Infect Dis. 2012 Jun;54(11):1642-51. doi: 10.1093/cid/cis251. Epub 2012 Apr 10.

4.

Effects of tesamorelin on inflammatory markers in HIV patients with excess abdominal fat: relationship with visceral adipose reduction.

Stanley TL, Falutz J, Mamputu JC, Soulban G, Potvin D, Grinspoon SK.

AIDS. 2011 Jun 19;25(10):1281-8. doi: 10.1097/QAD.0b013e328347f3f1.

5.

Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data.

Falutz J, Mamputu JC, Potvin D, Moyle G, Soulban G, Loughrey H, Marsolais C, Turner R, Grinspoon S.

J Clin Endocrinol Metab. 2010 Sep;95(9):4291-304. doi: 10.1210/jc.2010-0490. Epub 2010 Jun 16.

PMID:
20554713
6.

Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.

Falutz J, Potvin D, Mamputu JC, Assaad H, Zoltowska M, Michaud SE, Berger D, Somero M, Moyle G, Brown S, Martorell C, Turner R, Grinspoon S.

J Acquir Immune Defic Syndr. 2010 Mar;53(3):311-22. doi: 10.1097/QAI.0b013e3181cbdaff.

PMID:
20101189
7.

Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation.

Falutz J, Allas S, Mamputu JC, Potvin D, Kotler D, Somero M, Berger D, Brown S, Richmond G, Fessel J, Turner R, Grinspoon S.

AIDS. 2008 Sep 12;22(14):1719-28. doi: 10.1097/QAD.0b013e32830a5058.

PMID:
18690162
8.

Beneficial effects of gliclazide modified release compared with glibenclamide on endothelial activation and low-grade inflammation in patients with type 2 diabetes.

Räkel A, Renier G, Roussin A, Buithieu J, Mamputu JC, Serri O.

Diabetes Obes Metab. 2007 Jan;9(1):127-9. No abstract available.

PMID:
17199728
9.
10.

The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy.

Serri O, Li L, Mamputu JC, Beauchamp MC, Maingrette F, Renier G.

Clin Endocrinol (Oxf). 2006 Apr;64(4):366-70.

PMID:
16584506
14.

Lack of concordance between plasma markers of cardiovascular risk and intima-media thickness in patients with type 2 diabetes.

Moussavi N, Renier G, Roussin A, Mamputu JC, Buithieu J, Serri O.

Diabetes Obes Metab. 2004 Jan;6(1):69-77.

PMID:
14686966
15.

Antiatherogenic properties of metformin: the experimental evidence.

Mamputu JC, Wiernsperger NF, Renier G.

Diabetes Metab. 2003 Sep;29(4 Pt 2):6S71-6. Review.

PMID:
14502103
16.

Benefits of gliclazide in the atherosclerotic process: decrease in monocyte adhesion to endothelial cells.

Renier G, Mamputu JC, Serri O.

Metabolism. 2003 Aug;52(8 Suppl 1):13-8. Review.

PMID:
12939734
17.

Monocyte adhesion in diabetic angiopathy: effects of free-radical scavenging.

Renier G, Mamputu JC, Desfaits AC, Serri O.

J Diabetes Complications. 2003 Mar-Apr;17(2 Suppl):20-9.

PMID:
12623165
19.
20.

Proliferative effect of lipoprotein lipase on human vascular smooth muscle cells.

Mamputu JC, Levesque L, Renier G.

Arterioscler Thromb Vasc Biol. 2000 Oct;20(10):2212-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk